Report
mRNA COVID vaccines may help some cancer immunotherapy work better
Science News reports a Nature study found lung cancer patients who got an mRNA COVID vaccine near checkpoint-inhibitor treatment lived longer, though researchers say the effect is not yet proven.
TLDR
Science News reports a Nature study found lung cancer patients who received an mRNA COVID vaccine within about 100 days of checkpoint-inhibitor immunotherapy lived markedly longer than unvaccinated patients, with a similar pattern in melanoma. Mouse data suggest a possible immune explanation, but researchers say the result is still a correlation and needs a clinical trial.
Combined views
123.9K
2 Sources, first seen ago